The efficacy of intradermal hyaluronic acid filler as a skin quality booster: A prospective, single-center, single-arm pilot study

被引:0
|
作者
Lee, Joo Hee [1 ,2 ]
Kim, Jemin [3 ,4 ]
Lee, Yun Na [1 ,2 ]
Choi, Sooyeon [1 ,2 ]
Lee, Young In [1 ,2 ,3 ]
Suk, Jangmi [5 ]
Lee, Ju Hee [1 ,2 ,3 ,6 ,7 ]
机构
[1] Yonsei Univ, Dept Dermatol, Coll Med, Severance Hosp, Seoul, South Korea
[2] Yonsei Univ, Severance Hosp, Cutaneous Biol Res Inst, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Yonsei Canc Hosp, Scar Laser & Plast Surg Ctr, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Yongin Severance Hosp, Dept Dermatol, Gyeonggi Do, South Korea
[5] Global Med Res Ctr, Seoul, South Korea
[6] Yonsei Univ, Coll Med, Dept Dermatol, 50-1 Yonsei Ro, Seoul 03722, South Korea
[7] Yonsei Univ, Cutaneous Biol Res Inst, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
关键词
filler; hyaluronic acid; skin aging; NONANIMAL ORIGIN; GEL; FACE;
D O I
10.1111/jocd.15944
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundThe use of "skin boosters" comprised of hyaluronic acid (HA)-based fillers to improve skin quality has gained popularity recently, especially in individuals interested in skin rejuvenation.AimThis study aimed to evaluate the efficacy and safety of intradermal micropuncture injections of HA-based gel filler combined with lidocaine (BYRYZN & REG; SKINBOOSTER HA, ACROSS Co., Ltd., Gangwon-do, Korea).Patients/MethodsA prospective, single-arm, open-label pilot study was conducted with study subjects who were aged between 30 and 60 years old and exhibited evidence of skin aging, such as wrinkles and loss of elasticity. They received three injections at 2-week intervals and were followed up for a total of 12 weeks.ResultsTwenty subjects with a mean age of 54.1 years were included. The mean Lemperle wrinkle scale demonstrated a 40% decrease from 2.60 & PLUSMN; 0.60 at baseline to 1.55 & PLUSMN; 0.51 at week 8. The improvement rate was maintained at about 33% until week 12. The average maximum height of the wrinkle (Rz, & mu;m), average skin roughness (Ra, & mu;m), skin elasticity (R2, AU), facial curved length (mm), skin pore size (mm2), skin hydration (AU), TEWL (g/hm2), and skin glossiness (gloss value, AU) exhibited statistically significant improvements over time compared with the baseline measurements. No serious adverse effects or persistent adverse effects were reported, except for a transient subcutaneous nodule in one subject.ConclusionsThis study demonstrates that multiple microinjections of HA-based gel filler for facial skin aging are safe and effective in improving facial skin quality.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 50 条
  • [31] Long-term efficacy analysis of radiotherapy and local management of metastases in patients with newly diagnosed oligometastatic nasopharyngeal carcinoma: A prospective, single-arm, single-center clinical study
    Huang, Shuang
    Jiang, Feng
    Cao, Caineng
    Jin, Qifeng
    Jin, Ting
    Hua, Yonghong
    Chen, Xiaozhong
    RADIOTHERAPY AND ONCOLOGY, 2024, 196
  • [32] Oral nitroglycerin solution for oesophageal food impaction: a prospective single-arm pilot study
    Willenbring, Benjamin Aaron
    Schnitker, Callie Korliss
    Stellpflug, Samuel J.
    EMERGENCY MEDICINE JOURNAL, 2020, 37 (07) : 434 - +
  • [33] Esmolol Infusion in Patients with Septic Shock and Tachycardia: A Prospective, Single-Arm Pilot Study
    Brown, S. M.
    Beesley, S.
    Lanspa, M.
    Grissom, C.
    Wilson, E.
    Parikh, S.
    Sarge, T.
    Talmor, D.
    Banner-Goodspeed, V.
    Novack, V.
    Thompson, B.
    Shahul, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [34] Durability of Glucose-Lowering Effect of the First Administration of Dulaglutide: A Retrospective, Single-Center, Single-Arm Study
    Matsushita, Maya
    Chujo, Daisuke
    Tonoike, Mie
    Kajio, Hiroshi
    DIABETES THERAPY, 2018, 9 (05) : 2127 - 2132
  • [35] Durability of Glucose-Lowering Effect of the First Administration of Dulaglutide: A Retrospective, Single-Center, Single-Arm Study
    Maya Matsushita
    Daisuke Chujo
    Mie Tonoike
    Hiroshi Kajio
    Diabetes Therapy, 2018, 9 : 2127 - 2132
  • [36] Milk Oral Immunotherapy: A Single-Center Pilot Study of Safety and Efficacy
    Saltzman, R. W.
    Kelleher, M.
    Brown-Whitehorn, T.
    Fiedler, J.
    Corry, J.
    Gober, L.
    Dudek, E.
    Cianferoni, A.
    Spergel, J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB25 - AB25
  • [37] TOCILIZUMAB MONOTHERAPY FOR POLYMYALGIA RHEUMATICA ∼ RESULTS OF 52-WEEK TREATMENT OF A PROSPECTIVE, SINGLE-CENTER, OPEN, SINGLE-ARM TRIAL
    Amano, K.
    Chino, K.
    Okada, Y.
    Shibata, A.
    Okuyama, A.
    Kurasawa, T.
    Takei, H.
    Kondo, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1399 - 1399
  • [38] First Line Combination of Toripalimab and Chemotherapy in Advanced Thymic Carcinoma: A Single-Center, Prospective, Single-Arm, Phase II Trial
    Hu, X.
    Feng, Y.
    Zhu, H.
    Lu, J.
    Liu, Y.
    Xing, P.
    Wang, H.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S331 - S331
  • [39] Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma:A single-center, prospective,single-arm clinical trial
    Yupeng Ren
    Yuxuan Li
    Mingbo Cao
    Yongchang Tang
    Feng Yuan
    Gaoyuan Yang
    Zhiwei He
    Zheng Shi
    Xiaorui Su
    Zhicheng Yao
    Meihai Deng
    Chinese Journal of Cancer Research, 2024, 36 (02) : 114 - 123
  • [40] Efficacy and safety of cold forceps biopsy for diminutive pharyngeal neoplasms: Single-center, prospective pilot study
    Shimodate, Yuichi
    Itakura, Junya
    Sunami, Tomohiko
    Ueno, Masayuki
    Ishikawa, Sho
    Hira, Daichi
    Takayama, Hiroshi
    Sumiya, Tomoki
    Sue, Masahiko
    Takezawa, Rio
    Doi, Akira
    Nishimura, Naoyuki
    Mouri, Hirokazu
    Matsueda, Kazuhiro
    Yamamoto, Hiroshi
    Mizuno, Motowo
    DIGESTIVE ENDOSCOPY, 2021, 33 (05) : 761 - 769